Step Three

Step Three: Submit Your Abstract

Submitting authors must create an account and submit abstracts online. No faxed or mailed abstracts will be accepted. There is a $60 non-refundable processing charge per abstract. There is a $120 fee for late-breaking abstracts. Please note that this is a processing fee, not a publishing fee, and that abstracts not selected for presentation at DDW are also subject to the fee. Refunds will not be offered for any abstracts not selected for DDW 2018 or to any presenting authors who are not able to attend DDW.

Abstracts are not considered submitted until payment information has been received. Authors have the option of paying by Visa®, MasterCard® or American Express®. No invoices, purchase orders or checks will be accepted. Authors may edit submitted abstracts until the submission deadline on Dec. 1, 2017.

Authors may make edits to submitted abstracts any time prior to the Dec. 1 submission deadline. To make edits, submitting authors should log in at the submission site, click the “submission” tab and use the dropdown menu next to the abstract title to select “return to draft.” The abstract will then be available for editing. Once all changes have been made, authors must save and resubmit the abstract. Please note that authors must resubmit an abstract that has be edited after the initial submission. Any abstracts in draft status at the submission deadline will not be reviewed or considered for presentation at DDW. There is no charge to resubmit an abstract.

Rules for Submission

By submitting an abstract, the contact author certifies that he and any co-authors listed on the abstract have read and agree to the following DDW 2018 Rules for Submission. Violations of any DDW policies may result in a five-year sanction from submitting abstracts to DDW for the submitting author.

Commitment to Present

  • Submission of an abstract constitutes a commitment by the author(s) to present if the abstract is accepted. Failure to present may jeopardize acceptance of future abstracts. Abstracts may be presented only by authors listed in the author string at the time of submission.

  • All presentations at DDW 2018 will be in English. Oral abstract presentations must be made by an author who speaks and understands English.

  • Expenses associated with the submission and presentation of an abstract are the sole responsibility of the presenting author. Presenters are required to register for the meeting. Registration opens on Wednesday, Jan. 17, 2018, for society members and Wednesday, Jan. 24, 2018, for nonmembers.

Previous Presentation, Publication and Duplication

  • Abstracts will not be considered for presentation if they have been, or will be presented before DDW in the U.S. at a national meeting of a society with the exceptions of the ACS Surgical Forum, the NASPGHAN Annual Meeting and the Crohn's & Colitis Congress™.

  • Abstracts will be considered for presentation if they were, or will be, presented at national meetings in countries outside of the U.S.
  • Abstracts will not be considered for presentation if they have been published as an article or have been accepted for publication (including manuscripts) in printed or electronic formats upon the Dec. 1 submission deadline.

  • Abstracts submitted to the SSAT will not be considered for oral presentation if they have been or will be published as an article or accepted for publication (including manuscripts) in printed or electronic formats before DDW. Abstracts selected for SSAT Plenary presentation are required to submit a manuscript at the time of the meeting for publication consideration in the Journal of Gastrointestinal Surgery. Failure to do so will result in a three-year sanction from submitting abstracts for all authors. The exception to this SSAT rule is that authors of basic science abstracts submitted to the SSAT may request a waiver from this manuscript submission requirement at the time of abstract submission. Additionally, abstracts submitted to the SSAT for oral presentation should not be submitted to or reviewed for consideration by other journals before DDW 2018.

  • Abstracts will not be considered for presentation if they have been duplicated in any way. Abstracts may not be submitted to more than one category, subcategory or society for DDW. Abstracts that have been submitted to DDW in previous years but not accepted for presentation are eligible for submission.

  • DDW reserves the right to impose a five-year sanction on any author who submits an abstract that has been duplicated in any way or submits an abstract to more than one category, subcategory or society.

Corresponding Authors

The corresponding author certifies that all authors named in his abstract have agreed to its submission for presentation at DDW 2017, and that any animal studies conform with the October 2014 revision of The Guiding Principles in the Care and Use of Vertebrate Animals in Research and Training by the American Physiological Society; and that any human experimentation conducted conforms with the principals of the Declaration of Helsinki of the World Medical Association and meets all the requirements governing informed consent of the country in which the research was performed.

Co-Author Participation

By submitting an abstract, the corresponding author affirms that his co-authors have participated sufficiently in the intellectual content, the analysis of data and the writing of the abstract to take public responsibility for it.

Ethical Statement

Corresponding authors affirm that they and the other authors submitting an abstract to DDW certify that the data included in their abstract submission and/or presented at DDW is truthful, original, unduplicated and without fraud or fabrication.

Abstract Copyright Transfer Agreement and Release for Recording

By submitting an abstract, the corresponding author certifies that all authors named in the abstract have read and understand the terms of the Abstracts Copyright Transfer Agreement, which states:

“The corresponding author hereby assigns, conveys, and otherwise transfers all rights, title, interest, and copyright ownership in said work to the four sponsoringsocieties of DDW effective upon acceptance of said work for publication. ‘Work’ includes the material submitted for publication and any other related material submitted to DDW. The assignment of rights to the four sponsoring societies of DDW includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, prepare derivative works, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time ofexecution of this agreement, and claim copyright in said work throughout the world for the full duration of the copyright and any renewals or extensions thereof.”

U.S. Government Employee Authors: The corresponding author warrants that the work was authored by employees of the U.S. government as part of their official duties and therefore may be published and reproduced without restriction.

Disclosure Compliance

  • All authors are required to complete the disclosure process at the abstract submission site either disclosing all financial relationships with commercial interests or indicating that none exist. The deadline for completing disclosure is Friday, Dec. 15, 2017, at 3 p.m. ET.

  • Upon submission of an abstract, co-authors that have not submitted their disclosure for DDW 2018 will receive an email alert directing them to the abstract submission site with instructions to submit their disclosure.

  • It is the submitting author’s responsibility to ensure that all co-authors submit their financial disclosure for DDW 2018. Abstracts missing co-author financial disclosures will be in jeopardy of not being reviewed and involuntarily withdrawn from DDW 2018.

  • As part of the disclosure process, authors will be asked if they have any relationships with commercial interests. Authors with such relationships will be asked to list the name(s) of the companies with which they are involved, the benefits received (e.g., salary, consulting fee, ownership interest, etc.) and any roles they play within the named commercial entities (e.g., advisory committee member, board member, employee, shareholder, etc.). Authors without relationships may state that they have no information to disclose.

  • Submitting authors are not permitted to submit a disclosure on a co-author’s behalf.

Additional AGA Rules

AGA Institute Oral and Poster Abstract Submission
  • AGA welcomes abstract submissions from all career levels for consideration of oral or poster presentation.

  • Please carefully and thoroughly review the AGA Institute Council's Expanded Descriptors, available beginning Oct. 19 at the submission site, to find the best category and subcategory for your abstract submission.

AGA GI Fellow-Directed QI Session Abstract Submission
  • AGA will accept submissions for oral and/or poster presentation at a special fellow-directed session focusing on quality improvement.

  • Only those currently enrolled in a GI fellowship program may submit abstracts to this descriptor category.

  • The GI fellow MUST be the primary author on the abstract submission.

  • Medical residents are not eligible to submit abstracts to this category.

  • Abstracts submitted and accepted under this category are only eligible for presentation at the special quality improvement session.

  • Please select “GI Fellow-Directed QI Session” for your category and subcategory only if you are submitting for this session.

Additional SSAT Rules

  • An author can have more than one abstract accepted for SSAT podium presentation (including Plenary and Quick Shot oral presentations as well as video presentations) but can present only one of those podium presentations. In this case, unique co-authors must present the other podium presentations. There is no limit on the number of posters accepted per author, institution or subject.

  • Authors of abstracts selected for SSAT Plenary presentations are required submit a manuscript at the time of the meeting for potential publication in the Journal of Gastrointestinal Surgery. Failure to do so will result in the prevention of future abstract submissions for a period of three years for all authors. The exception to this SSAT rule is that authors of basic science abstracts submitted to the SSAT may request a waiver from this manuscript submission requirement at the time of abstract submission. Additionally, abstracts submitted to the SSAT for oral presentation should not be submitted to or reviewed for consideration by other journals before DDW.

  • If an abstract is accepted for a Quick Shot or poster presentation, authors are encouraged to submit a manuscript for potential publication in the Journal of Gastrointestinal Surgery.

  • If an abstract selected for an SSAT Plenary or Quick Shot presentation describes the use of a device, product or drug that is not FDA approved; off-label use of an approved device, product or drug; or unapproved usage of a device, product or drug, the presenting author will disclose this information verbally to the learner during his or her presentation.

Continue On


Step Four

All authors are required to complete the disclosure process.

Go to Step Four


Step Five

Learn how you will be notified of acceptance, published and presentation details.

Go to Step Five


FAQs

Read the guide and still have questions? Get your answers here.

Go to FAQs